Exchange: NYSE·Updated 01:20 AM EDT

BSX News

News
all
press releases
BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?
Boston Scientific faces near-term pressure in electrophysiology, while Medtronic gains share and sees stronger momentum across key franchises.
Zacks
More News
New Strong Sell Stocks for September 16th
AGCO, BSX and BBWI have been added to the Zacks Rank #5 (Strong Sell) List on September 16th, 2026.
Zacks
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.01% on an annualized basis producing an average annual return of 14.1%. Currently, Boston Scientific has a market capitalization ofread more...
Benzinga
Boston Scientific Leans on Acquisitions to Drive Long-Term Growth
BSX's deal-making push expands its reach into high-growth markets, with Penumbra adding a major thrombectomy opportunity.
Zacks
Boston Scientific (BSX) Didn't Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.
Boston Scientific (BSX) Didn't Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance...
Yahoo! Finance: News
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Boston Scientific (BSX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks
Why Boston Scientific (BSX) Dipped More Than Broader Market Today
Boston Scientific (BSX) reached $43.1 at the closing of the latest trading day, reflecting a -4.14% change compared to its last close.
Zacks
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum
MDT lifts its 2027 outlook as broad-based growth accelerates, but margin pressure and competition could test momentum.
Zacks
Boston Scientific Says Cyberattack Will Impact 2026 Results — Says It Is ‘Unlikely’ To Meet Net Sales Growth, EPS Guidance Ranges
Boston Scientific expects to provide updated full-year 2026 guidance along with its third-quarter results on Oct. 28, 2026.
Stocktwits
Boston Scientific Says It Won't Meet 2026 Guidance After Cyberattack
Boston Scientific expects a 2026 earnings miss after a cyberattack disrupted global operations. Manufacturing and shipping are recovering.read more...
Benzinga

Advertisement|Remove ads.